ARKG
- ARK Genomic Revolution ETF關鍵資訊
| 最早日期 | 2014-10-31 |
ETF 資訊
| 基金提供者 | ARK Invest |
| 指數 | Active (No Index) |
| 費用率 | 0.75% |
| 持倉數量 | 42 |
| 成立日期 | 2014-10-31 |
| 資產類別 | Equity |
| 上市地 | US-listed |
| 產業 | Healthcare |
| 投資風格 | Growth |
| 非槓桿型 | Non-leveraged |
關於 ARKG
The ARK Genomic Revolution ETF is an actively managed fund that invests in companies driving advancements in genomics, gene editing, genetic therapy, molecular diagnostics, and stem cell advances. The fund's portfolio is tilted towards smaller firms and is designed to capture long-term growth potential in the healthcare and biotechnology sectors.